This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive | MicrobiomeTrials
← Back to trials NCT07413939
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Recruiting PHASE2, PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-05-21Est. Completion: 2029-05-01
Enrollment target: 650 participantsLocations Monash Health, Clayton, Victoria, Australia Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Cliniques Universitaires St-Luc, Brussels, Belgium UZ Leuven Gasthuisberg, Leuven, Belgium AZ St Maarten Campus Leopoldstr, Mechelen, Belgium Princess Margaret Cancer Center, Toronto, Ontario, Canada Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada McGill University Health Centre - Glen Site, Montreal, Quebec, Canada Hopital du Saint Sacrement, Québec, Quebec, Canada Cancer Hospital Chinese Academy of Medical Sciences., Beijing, China Dres. Andreas Köhler und Roswitha Fuchs, Langen, Germany Rotkreuzklinikum München, München, Germany IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna, Italy A.O. Universitaria Di Parma, Parma, Emilia-Romagna, Italy Irccs Centro Di Riferimento Oncologico (CRO), Aviano, Friuli Venezia Giulia, Italy Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy Other microbiome trials you might be interested in Early Breast Cancer
This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant g…
Daphne, United States Est. completion Aug 8, 2025
Breast Cancer
In the phase I part, to determine the recommended doses (RD) and dosing regimens of \[177Lu\]Lu-NeoB in combination with…
Los Angeles, United States Est. completion Sep 9, 2031
Università Campus Bio-Medico di Roma, Rome, Lazio, Italy
Istituto Clinico Humanitas, Rozzano, Lombardy, Italy
Humanitas Centro Catanese Di Oncologia, Misterbianco (CT), Sicily, Italy
Uniwersyteckie Centrum Kliniczne im. K. Gibinskiego SUM, Katowice, Poland
Szpital Uniwersytecki w Krakowie, Krakow, Poland
Szpital Kliniczny Ministerstwa Spraw Wewn?trznych i Administracji z Warmi?sko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn, Poland
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna, Poland
NU-MED Centrum Diagnostyki i Terapii Onkologicznej, Tomaszów Mazowiecki, Poland
Dolno?l?skie Centrum Onkologii, Wroc?aw, Poland
Hospital Beatriz Angelo, Loures, Portugal
Hospital Pedro Hispano, Matosinhos Municipality, Portugal
Medical Oncology Centre of Rosebank, City of Johannesburg, South Africa
Hospital Universitario Virgen de La Arrixaca, EL Palmar (EL Palmar), Murcia, Spain
Hospital Clinic Provincial, Barcelona, Spain
Hospital Universitario San Cecilio, Granada, Spain
Complejo Hospitalario de Jaen, Jaén, Spain
IOB Madrid Institute of Oncology Hospital Beata Maria Ana de Jesus;Unidad Central de Oncología Médica y de Investigación Oncológica, Madrid, Spain
Hospital General Universitario Gregorio Marañon, Madrid, Spain
Hospital Ramon y Cajal, Madrid, Spain
Hospital Universitario 12 De Octubre, Madrid, Spain
Taichung Veterans General Hospital, Taichung, Taiwan
National Cheng Kung University Hospital, Tainan, Taiwan
National Taiwan Uni Hospital, Taipei, Taiwan
Taipei Veterans General Hospital, Taipei, Taiwan
Chang Gung Memorial Hospital - Linkou, Taoyuan City, Taiwan
Ramathibodi Hospital, Bangkok, Thailand
Faculty of Med. Siriraj Hosp., Bangkok, Thailand
Srinagarind Hospital, Khon Kaen Uni, Khon Kaen, Thailand
Chulabhorn Hospital, Lak Si, Thailand
Songklanagarind Hospital, Songkhla, Thailand
Bangkok Metropolitan Administration Medical College and Vajira Hospital, Wachira Phayaban, Thailand
Hacettepe University Medical Faculty, Altındağ, Turkey (Türkiye)
Abdurrahman Yurtarslan Onkoloji Training and Research Hospital, Ankara, Turkey (Türkiye)
Trakya University Medical Faculty, Erdine, Turkey (Türkiye)
Istinye University Liv Hospital Topkapi, Istanbul, Turkey (Türkiye)
Marmara University Pendik Research and Training Hospital, Istanbul, Turkey (Türkiye)
Mersin City Education and Research Hospital, Mersin, Turkey (Türkiye)
Medikal Park Samsun, Samsun, Turkey (Türkiye)
Christie Hospital Nhs Trust, Manchester, United Kingdom